ADCT position history
The shares of Adc Therapeutics (ADCT) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 682,529 shares, $2.7M, 0.39% of portfolio, New
- 2025 Q4: not held, Exit
- 2026 Q1: not held
- 2026 Q2: 700,000 shares, $749K, 0.07% of portfolio, New
- 2026 Q3: 4,070,819 shares, $5M, 0.56% of portfolio, Add +481.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|